Deepdive – Research and Development 2024
Language: NL
About the project
In this issue, pharmaphorum editor-in-chief Jonah Comstock hits the floor at the 42nd annual JP Morgan Health conference to find out how attitudes towards AI in R&D are changing, blood donation centres infuse new life into the cell and gene therapy space, and we find out what it takes to navigate the complex and evolving landscape of clinical trial supply management.
Client
Creation
Product
Sector
Other editions
View other editions of this magazine
Consent has long been a controversial and complex debate for pharma. While the industry has actively placed great emphasis on efforts to promote the patient voice as the heart of development efforts in recent years, the role and rights of patients in medical research have not always been so clear-cut.
In this issue of Deep Dive, we take a look back at the storied history of the UK’s National Health Service to mark the organisation’s 75th anniversary, plus Lumanity’s Gagandeep Sawant and Lindsay Lare offer a simple framework to help guide companies along their journey of choosing the right omnichannel partner.
Getting the right treatment to the right patient at the right time is the backbone of market access. However, as with many things in life, the reality of achieving this goal is often far more complex than it is on paper.
